Bausch & Lomb Incorporated

🇺🇸United States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-10-01
Last Posted Date
2024-12-13
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
140
Registration Number
NCT06618547

A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2024-09-13
Last Posted Date
2024-09-13
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
450
Registration Number
NCT06594185
Locations
🇺🇸

Site 118, Birmingham, Alabama, United States

🇺🇸

Site 105, Tucson, Arizona, United States

🇺🇸

Site 104, Bakersfield, California, United States

and more 17 locations

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2024-08-22
Last Posted Date
2024-12-17
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
216
Registration Number
NCT06565650
Locations
🇺🇸

Site 101, Glendale, California, United States

🇺🇸

Site 112, Murrieta, California, United States

🇺🇸

Site 102, Newport Beach, California, United States

and more 9 locations

Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens

First Posted Date
2024-06-28
Last Posted Date
2024-10-21
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
80
Registration Number
NCT06479148
Locations
🇭🇳

Site 101 Centro Oftalmológico Robles, Santa Rosa De Copán, Copán, Honduras

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2024-04-04
Last Posted Date
2024-11-18
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
100
Registration Number
NCT06346340
Locations
🇺🇸

Site 109, Sacramento, California, United States

🇺🇸

Site 111, Grand Junction, Colorado, United States

🇺🇸

Site 108, Alexandria, Minnesota, United States

and more 9 locations

A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Recruiting
Conditions
Interventions
First Posted Date
2024-03-27
Last Posted Date
2024-12-11
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
100
Registration Number
NCT06333028
Locations
🇺🇸

Site 107, Cranberry Township, Pennsylvania, United States

🇺🇸

SITE 104, Dover, New Jersey, United States

🇺🇸

Site 105, Woodland Park, New Jersey, United States

and more 4 locations

Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

First Posted Date
2024-03-27
Last Posted Date
2024-11-18
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
224
Registration Number
NCT06333015
Locations
🇺🇸

Site 106, Sioux Falls, South Dakota, United States

🇺🇸

Site 103, Dallas, Texas, United States

🇺🇸

Site 111, Mount Pleasant, Wisconsin, United States

and more 6 locations

A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease

Phase 4
Completed
Conditions
Interventions
First Posted Date
2024-03-13
Last Posted Date
2024-06-21
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
99
Registration Number
NCT06309953
Locations
🇺🇸

Site 203, Pittsburg, Kansas, United States

🇺🇸

Site 202, Kansas City, Missouri, United States

🇺🇸

Site 204, Stillwater, Minnesota, United States

and more 2 locations

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

First Posted Date
2024-03-12
Last Posted Date
2024-05-23
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
418
Registration Number
NCT06305663
Locations
🇨🇳

Site 103, Chengdu, Sichaun Province, China

🇨🇳

Site 110, Wuhan, Hubei, China

🇨🇳

Site 105, Beijing, Beijing, China

and more 8 locations

Kalifilcon A Toric Compared to Commercially Available Lenses

First Posted Date
2023-10-25
Last Posted Date
2024-12-10
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
30
Registration Number
NCT06098937
Locations
🇺🇸

Bausch & Lomb, Incorporated, Rochester, New York, United States

© Copyright 2024. All Rights Reserved by MedPath